Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJudges Scientific Regulatory News (JDG)

Share Price Information for Judges Scientific (JDG)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 11,375.00
Bid: 11,200.00
Ask: 11,550.00
Change: -100.00 (-0.88%)
Spread: 350.00 (3.125%)
Open: 11,275.00
High: 11,200.00
Low: 11,200.00
Prev. Close: 11,300.00
JDG Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Acquisition of Dia-Stron Limited

1 Apr 2016 07:00

RNS Number : 8058T
Judges Scientific PLC
01 April 2016
 

Press Release

1 April 2016

 

Judges Scientific plc

 

("Judges Scientific", "Judges", the "Company" or the "Group")

 

Acquisition of Dia-Stron Limited

 

 

Judges Scientific, a group involved in the buy and build of scientific instrument businesses, announces that it has today acquired 100% of the issued share capital of Dia-Stron Limited ("Dia-Stron"), an instrument maker based in Andover, Hampshire. Dia-Stron designs and manufactures systems to test the mechanical properties of fibres (the "Acquisition"). The Board expects the Acquisition to be immediately earnings enhancing.

 

The purchase price of Dia-Stron amounted to £2.75 million in cash. An additional payment will be made to reflect any excess working capital over and above the ongoing requirements of the business. The Board expects such payment to be covered by the cash inherited at the completion date.

 

Information on Dia-Stron

Dia-Stron specialises in the design and manufacture of systems to test the mechanical properties of fibres, primarily in relation to tensile strength. The company is a market leader in testing natural hair fibres and approximately 75 per cent of revenues are derived from the hair care industry, including large multi-national groups. The balance of sales is comprised of industrial fibres, skin-testing instruments and contract testing for third parties. The automation built into the company's systems provides significant efficiency savings for customers.

 

All of Dia-Stron's products are designed by the company, manufactured in Hampshire and sold worldwide to end users directly, through agents or through the company's US office ("Dia-Stron US"). The company's contract testing activities have, historically, been conducted in the US by Mar-Tech Contract Services Inc., a related company ("Mar-Tech); these activities, along with certain assets of Dia-Stron US, were transferred to Dia-Stron in the UK prior to completion of the Acquisition.

 

Dia-Stron was established in 1987 by Dr Nigel Winsey (Managing Director), Mrs Lynn Winsey (Finance Director and Company Secretary), Dr Steve Bucknell (Technical Director) and Mrs Tessa Bucknell (shareholder). Dr Winsey will continue as Managing Director until the end of the year to facilitate a smooth transition and Dr Bucknell will remain with the company as Technical Director.

 

Dia-Stron's stand-alone accounts for the financial year to 31 March 2015 show revenues of £1.48 million and pre-tax profits of £0.59 million. Net tangible assets amounted to £0.81 million, including cash of £0.55 million. These accounts do not include the assets or profits of Dia-Stron US and Mar-Tech which were acquired by Dia-Stron prior to completion of the Acquisition and are not material in the context of the transaction.

 

Dia-Stron's operating profits for the 12-month period ended 30 August 2015, adjusted (i) to include the profit contribution of Dia-Stron US and an estimate of the recurring annual profit of Mar-Tech and (ii) to eliminate non-recurring items and to reflect Dia-Stron's ongoing cost base within Judges, would have totalled £0.66 million on sales of £1.67 million. Dia-Stron owns a long leasehold property valued at £0.14 million.

 

Financing of the Acquisition

The Acquisition and associated transaction costs are being financed from Judges' existing cash resources.

 

The Board believes that Dia-Stron is an attractive and highly innovative business which enjoys a strong position in its worldwide niche market and an excellent reputation for quality and service.

 

Alex Hambro, Chairman of Judges, commented:

 

"Dia-Stron is an excellent company which has developed a first class reputation in its niche market and can be expected to have a positive and immediate impact on the Group's financial performance. We are delighted to welcome Nigel, Steve and their colleagues to Judges' management team."

 

- Ends -

 

 

 

 

For further information please contact:

 

 

Judges Scientific plc

David Cicurel, CEO

Brad Ormsby, FD

 

Tel: 020 3829 6970

 

Shore Capital (Nominated Adviser & Broker)

Stephane Auton

Edward Mansfield

 

Tel: 020 7408 4090

 

Abchurch (Financial Public Relations)

Philip Dennis

Quincy Allan

Nessyah Hart

Tel: 020 7398 7700

 

 

 

 

Notes to editors:

Judges Scientific plc (AIM: JDG), is a group involved in the buy and build of scientific instrument businesses. The Group currently consists of 14 businesses acquired since it was first admitted to AIM in 2003.

 

The acquired companies are primarily UK-based with products sold worldwide to a diverse range of markets including: higher education institutions, the scientific communities, manufacturers and regulatory authorities. The UK is a recognised centre of excellence for scientific instruments. The Group holds 5 Queens' awards for innovation and export.

 

Judges Scientific maintains a policy to selectively acquire businesses that generate sustainable profits and cash. Shareholder returns are created through the repayment of debt, organic growth and dividends.

The Group's companies predominantly operate in niche end markets, with long term growth fundamentals and resilient margins.

 

For further information, please visit www.judges.uk.com

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
ACQAKDDNBBKBDNN
Date   Source Headline
10th May 20223:59 pmRNSDirector/PDMR Shareholding
29th Apr 20229:13 amRNSNotice of AGM
25th Apr 20224:41 pmRNSHolding(s) in Company
22nd Apr 20223:37 pmRNSDirector/PDMR Shareholding
30th Mar 20223:26 pmRNSTotal Voting Rights
23rd Mar 20227:00 amRNSFinal Results
11th Mar 20227:00 amRNSDirector/PDMR Shareholding
23rd Feb 202210:44 amRNSDirector/PDMR Shareholding
14th Jan 202211:42 amRNSDirector/PDMR Shareholding
7th Jan 20227:00 amRNSFull Year Trading Statement and Notice of Results
8th Dec 20217:00 amRNSDirector/PDMR Shareholding
1st Dec 20219:57 amRNSTotal Voting Rights
30th Nov 20218:27 amRNSDirector/PDMR Shareholding
12th Nov 202111:10 amRNSDirector/PDMR Shareholding
10th Nov 20216:07 pmRNSDirector/PDMR Shareholding
1st Nov 20217:00 amRNSTotal Voting Rights
8th Oct 20219:26 amRNSDirector/PDMR Shareholding
28th Sep 20212:29 pmRNSDirector/PDMR Shareholding
24th Sep 20217:00 amRNSInterim Results
7th Sep 20212:20 pmRNSDirector/PDMR Shareholding
1st Sep 20212:34 pmRNSTotal Voting Rights
16th Aug 20217:00 amRNSDirector/PDMR Shareholding
2nd Aug 202112:19 pmRNSTotal Voting Rights
27th Jul 202111:29 amRNSDirector/PDMR Shareholding
22nd Jul 20217:00 amRNSHalf Year Trading Update and Notice of Results
9th Jul 202111:50 amRNSDirector/PDMR Shareholding
1st Jul 20217:00 amRNSTotal Voting Rights
10th Jun 20211:38 pmRNSBlock listing Interim Review
10th Jun 20219:49 amRNSDirector/PDMR Shareholding
28th May 20215:28 pmRNSPurchase of Ordinary Shares
28th May 20217:00 amRNSTotal Voting Rights
26th May 202112:53 pmRNSResult of AGM
26th May 20217:00 amRNSNew £60.0 million Bank Facility
20th May 202112:00 pmRNSAGM Q&A
11th May 20214:53 pmRNSDirector/PDMR Shareholding
10th May 20218:21 amRNSDirector/PDMR Shareholding
30th Apr 20217:00 amRNSTotal Voting Rights
29th Apr 202111:59 amRNSNotice of AGM
13th Apr 202111:39 amRNSDirector/PDMR Shareholding
1st Apr 202111:28 amRNSTotal Voting Rights
25th Mar 202111:58 amRNSDirector/PDMR Shareholding
23rd Mar 20217:00 amRNSFinal Results
10th Mar 20217:00 amRNSDirector/PDMR Shareholding
26th Feb 20217:00 amRNSTotal Voting Rights
16th Feb 20217:00 amRNSIncreased shareholding in Bordeaux Acquisition Ltd
9th Feb 20211:27 pmRNSDirector/PDMR Shareholding
29th Jan 20217:00 amRNSTotal Voting Rights
19th Jan 202111:57 amRNSDirector/PDMR Shareholding
8th Jan 20219:31 amRNSGrant of Options
7th Jan 20212:30 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.